🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with japan glp-1 access? Page 3

Has anyone dealt with japan glp-1 access?

Dr.PeteFamMed Fri, Oct 18, 2024 at 5:49 PM 35 replies 1,913 viewsPage 3 of 7
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Oct 19, 2024 at 2:21 PM#11
Dr.NateNeph said:
My experience ordering cross-border ordering internationally: I've ordered from a UK pharmacy.

That reframing is the part I needed.

5 5PurityPaulOR, MaxMetOK, MounjBrad and 2 others
Reply Quote Save Share Report
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
Oct 19, 2024 at 5:09 PM#12

Adding the clinical framing, because it changes how the question reads. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

Last edited: Oct 19, 2024 at 6:09 PM
4 4Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 1 other
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Oct 19, 2024 at 7:57 PM#13
Dr.GastroMayo said:
Start from the measurement rather than the conclusion.

I read this differently from Dr.GastroMayo, on substance rather than tone. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

3 3maya_sedona, stefan_berlin, Dr.EM_Chicago
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Oct 19, 2024 at 10:45 PM#14

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

Last edited: Oct 19, 2024 at 11:45 PM
2 2VendorMark, COA_Karl
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Oct 20, 2024 at 1:33 AM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Thread quality here is what the rules are for. Keep it up.

1 1PurityPaulOR
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register